Evidence map›Paper›PMID 32722122›Full record

ArticlePharmaceuticals (Basel, Switzerland)2020

Piperazine- and Piperidine-Containing Thiazolo[5,4-

Flavia Varano, Daniela Catarzi, Erica Vigiani, Fabrizio Vincenzi, Silvia Pasquini, Katia Varani, Vittoria Colotta

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Flavia VaranoDipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Sezione di Farmaceutica e Nutraceutica, Universita'degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino (FI), Italy.
Daniela CatarziDipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Sezione di Farmaceutica e Nutraceutica, Universita'degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino (FI), Italy.
Erica VigianiDipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Sezione di Farmaceutica e Nutraceutica, Universita'degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino (FI), Italy.
Fabrizio VincenziDipartimento di Morfologia, Chirurgia e Medicina Sperimentale, Università degli Studi di Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy.
Silvia PasquiniDipartimento di Morfologia, Chirurgia e Medicina Sperimentale, Università degli Studi di Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy.
Katia VaraniDipartimento di Morfologia, Chirurgia e Medicina Sperimentale, Università degli Studi di Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy.
Vittoria ColottaDipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Sezione di Farmaceutica e Nutraceutica, Universita'degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino (FI), Italy.

Funding

Università degli Studi di Firenze Fondi Ateneo Ricerca 2019
6 · The paper itself

Abstract

The therapeutic use of A

Indexed as

adenosine A2A receptor ligandsadenosine receptorsG protein-coupled receptorsthiazolo[5,4-d]pyrimidines

Identifiers

PMID32722122
PMCPMC7465344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.